Agios Pharmaceuticals, Inc. Financials

Market Capitalization $2.02 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	3.03
Forward PE	-5.82
Price to Sales TTM	$61.38
Price to Book MRQ	$1.24
Enterprise to Revenue	32.67
Enterprise to EBITDA	-2.68

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	2051.38%
Operating Margin	-1146.93%
Return on Assets TTM	-18.18%
Return on Equity TTM	53.65%

Income Statement

Revenue TTM	$32,871,000
Revenue per Share TTM	$0.58
Quarterly Revenue Growth	21.20%
Gross Profit TTM	$-266,584,992
EBITDA	$-401,288,000
Net Income to Common TTM	$674,307,968
Diluted EPS TTM	$11.66
Quarterly Earnings Growth YoY	21.15%

Balance Sheet

Total Cash MRQ	$1,004,756,992
Total Cash per Share MRQ	$17.62
Total Debt MRQ	$
Total Debt to Equity MRQ	3.74
Current Ratio MRQ	8.99
Book Value per Share MRQ	$28.53

Cash Flow

Operating Cash Flow TTM	$-329,161,984
Levered Free Cash Flow TTM	$-157,062,624

AGIO Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	57,030,200
Float Shares	50,506,511
Avg 10 Volume	793,770
Avg 30 Volume	None
Shares Short	5,526,130
Short Ratio	4.79
Short % of Shares	9.83%
% Held by Insiders	1.51%
% Held by Institutions	106.33%

Stock Price Summary

Beta	0.75
Fifty Two Week Low	$22.23
Fifty Two Week High	$62.58
Fifty Two Week Change	30.73%
Day 50 MA	$44.72
Day 200 MA	$42.58

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date